Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Campos-Gomez, S. [1 ]
Valdez-Andrade, J. J. [1 ]
Esquivel-Gutierrez, J. [1 ]
Jaimes Alpizar, E. [1 ]
Pacheco-Cuellar, G. [1 ]
Campos-Gomez, K. [1 ]
机构：
[1] Ctr Oncol Estatal Issemym, Thorac Oncol Unit, Toluca De Lerdo, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
nutrition risk; lung cancer; prognosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.11
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [21] Prognostic Factors for Overall Survival among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Verleger, Katharina
    Treur, Maarten
    Penrod, John
    Daumont, Melinda
    Lees, Michael
    Macahilig, Cynthia
    Solem, Caitlyn
    Jiang, Shan
    Chirita, Oana
    Hertel, Nadine
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S995 - S996
  • [22] The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients
    Hong, Shaodong
    Zhou, Ting
    Fang, Wenfeng
    Xue, Cong
    Hu, Zhihuang
    Qin, Tao
    Tang, Yanna
    Chen, Yue
    Ma, Yuxiang
    Yang, Yunpeng
    Hou, Xue
    Huang, Yan
    Zhao, Hongyun
    Zhao, Yuanyuan
    Zhang, Li
    TUMOR BIOLOGY, 2015, 36 (05) : 3389 - 3397
  • [23] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    Satouchi, M.
    Negoro, S.
    Funada, Y.
    Urata, Y.
    Shimada, T.
    Yoshimura, S.
    Kotani, Y.
    Sakuma, T.
    Watanabe, H.
    Adachi, S.
    Takada, Y.
    Yatabe, Y.
    Mitsudomi, T.
    BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1191 - 1196
  • [24] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    M Satouchi
    S Negoro
    Y Funada
    Y Urata
    T Shimada
    S Yoshimura
    Y Kotani
    T Sakuma
    H Watanabe
    S Adachi
    Y Takada
    Y Yatabe
    T Mitsudomi
    British Journal of Cancer, 2007, 96 : 1191 - 1196
  • [25] Distribution of Immune Markers and Their Association with Overall Survival and Time to Progression in Non-Small-Cell Lung Cancer (NSCLC)
    Kuykendall, Andrew T.
    Khalil, Farah
    Haura, Eric
    Antonia, Scott J.
    Schabath, Matthew
    Gabrilovich, Dmitry
    Creelan, Ben
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S268 - S269
  • [26] Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis
    Chen, Yunzhen
    Liu, Haichun
    Wu, Wenliang
    Li, Yi
    Li, Jianmin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [27] Surrogate end points for overall survival in patients with advanced non-small-cell lung cancer in trials of immunotherapy.
    Ou, Qiyun
    Yu, Yunfang
    Li, Anlin
    Chen, Yongjian
    Wang, Ying
    Ren, Wei
    Li, Chenchen
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis
    Yunzhen Chen
    Haichun Liu
    Wenliang Wu
    Yi Li
    Jianmin Li
    Journal of Experimental & Clinical Cancer Research, 32
  • [29] Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non-Small-Cell Lung Cancer
    Dranitsaris, George
    Beegle, Nancy
    Ravelo, Arliene
    Kalberer, Traci
    Yu, Elaine
    Thomas, Sachdev
    CLINICAL LUNG CANCER, 2013, 14 (02) : 120 - 127
  • [30] Modeling Tumor Dynamics and Overall Survival in Advanced Non-Small-Cell Lung Cancer Treated with Erlotinib
    Suleiman, Ahmed Abbas
    Frechen, Sebastian
    Scheffler, Matthias
    Zander, Thomas
    Kahraman, Deniz
    Kobe, Carsten
    Wolf, JRgen
    Nogova, Lucia
    Fuhr, Uwe
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 84 - 92
12345